Opioid Use Disorder: Developing Depot Buprenorphine Products for Treatment
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
February 7, 2019
January 17, 2020
f53ca142-5456-4eec-9cc0-358980e372cd
Related Documents
Allergic Rhinitis: Developing Drug Products for Treatment Guidance for Industry
Guidance DocumentSeptember 6, 2018Center for Drug Evaluation and Research
Nonallergic Rhinitis: Developing Drug Products for Treatment
Guidance DocumentSeptember 6, 2018Center for Drug Evaluation and Research
Migraine: Developing Drugs for Acute Treatment
Guidance DocumentFebruary 16, 2018Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox